Log in
Enquire now
‌

US Patent 11285125 Oxidative retinal diseases

Patent 11285125 was granted and assigned to Retrotope Inc. on March, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Retrotope Inc.
Retrotope Inc.
Current Assignee
Retrotope Inc.
Retrotope Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11285125
Patent Inventor Names
Mikhail S. Shchepinov0
Date of Patent
March 29, 2022
Patent Application Number
16106838
Date Filed
August 21, 2018
Patent Primary Examiner
‌
Lynn Y Fan
CPC Code
‌
A61K 31/122
‌
A61K 31/355
‌
A61P 39/06
‌
A61K 31/231
‌
A61P 3/10
‌
A61P 9/10
‌
A61K 31/201
‌
A61P 27/12
...

Some aspects of the invention provide for a method of treating Wet and/or Dry Age-related Macular Degeneration, Retinitis Pigmentosa, Diabetic Retinopathy, cataracts, and/or Stargardt Disease using polyunsaturated fatty acids which are modified in certain positions to attenuate oxidative damage by Reactive Oxygen Species (ROS) and/or suppress the rate of formation of reactive products and toxic compounds.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11285125 Oxidative retinal diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.